Johnson & Johnson logo

Executive Director AI-Native Biologics

Salary
$173K–$299K
Hiring from
United States
Work type
Hybrid
Posted

626,291 remote jobs, straight from company career pages

100% free · New jobs every minute

Show job description

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Discovery & Pre-Clinical/Clinical Development

Job Sub Function:

Biotherapeutics R&D

Job Category:

People Leader

All Job Posting Locations:

Cambridge, Massachusetts, United States of America, Spring House, Pennsylvania, United States of America

Job Description:

ABOUT JOHNSON & JOHNSON INNOVATIVE MEDICINE

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine



ABOUT THE OPPORTUNITY

Johnson & Johnson Innovative Medicine is seeking an Executive Director, AI-Native Biologics Modality Engineering, based in Spring House, Pennsylvania or Cambridge, Massachusetts.
This Executive Director, reporting to the VP of Biologics Discovery and a key member of the leadership team, will serve as the senior scientific leader for biologics modality engineering to enable AI-native biologics discovery. The leader will build and lead the scientific capabilities that translate disease biology, therapeutic intent, and computational design into differentiated biologic medicines, with function, developability, manufacturability, safety, and translational quality incorporated from the outset. The leader will connect modality strategy across therapeutic areas, protein engineering, in silico design, functional characterization, and translational quality as one integrated capability. The goal is to deliver molecules for today’s portfolio and to build durable platforms that learn across programs improving performance from discovery through CMC and future clinical development. This is not a stand-alone technology or engineering function. The role will work across In Silico Discovery, Therapeutic Areas, CMC, Safety, Translational Sciences, and Development to create reusable, translatable, and robust modality platforms. These platforms will use data, models, assays, engineering strategies, and decision frameworks to improve candidate choice, resolve downstream risk earlier, and increase the probability of development and clinical success.


KEY RESPONSIBILITIES

MODALITY DESIGN AND FUNCTIONAL QUALITY

• Translate portfolio intent into molecule design. Using AI-assisted tools, convert disease biology, mechanism, and target product profiles into explicit molecular-design and functional criteria across antibodies, multispecifics, ADCs, engineered proteins, and emerging biologic formats.

• Create candidate choice. Generate sufficient molecular diversity and decision-quality predictions and evidence to compare candidates with different strengths and tradeoffs, rather than advancing the first molecule that crosses a minimum threshold.

• Connect sequence, structure, and function. Integrate computational design, protein engineering, biophysical characterization, cell-based functional assays, and translational evidence into coherent design strategies and candidate decisions, while supporting powerful learning loops within the AI-native engine.

AI-NATIVE DISCOVERY EXECUTION

• Operate model-first learning loops. Embed predictive models, active learning, high-throughput experimentation, and automation directly into design-make-test-learn cycles; ensure data are generated to improve future models as well as the current molecule.

• Define the vertical requirements for shared platforms. Partner with In Silico Discovery and self-driving-laboratory leaders to identify the models, data standards, workflows, and automation needed by biologics programs, while avoiding duplicate infrastructure.

• Make performance measurable. Track design-round efficiency, predictive performance, cycle time, candidate diversity, platform reuse, and downstream molecule quality, and use the evidence to improve organizational effectiveness.

TRANSLATIONAL QUALITY FROM THE START

• Integrate development constraints early. Bring CMC, developability, exposure, safety, pharmacology, and clinical differentiation into molecular design while programs remain flexible and tradeoffs can still be managed.

• Resolve risk before handoff. Build the assays, data packages, and cross-functional reviews needed to identify weak concepts early and advance stronger candidates and platforms with a clearer rationale for downstream success.

• Build reusable quality platforms. Create scalable approaches for developability, manufacturability, function, and translational quality assessment that can be deployed across programs and modalities.

PLATFORM LEADERSHIP AND PARTNERSHIP

• Set modality and platform strategy. Define the scientific priorities, investment choices, and platform roadmap needed to create durable advantage across biologic modalities and the portfolio.

• Build and support an integrated multidisciplinary team. Recruit, develop, and connect scientific leaders and teams across protein engineering, protein sciences, functional biology, analytics, automation, and translational-quality disciplines.

• Shape the external ecosystem. Identify and integrate external science, technology, partnerships, and talent where they expand design possibilities, accelerate learning, or create durable competitive advantage.

• Represent the science. Communicate strategy, evidence, tradeoffs, and progress clearly to senior leaders, cross-functional partners, candidates, and external scientific audiences. This is not an exhaustive listing of job functions. The role may perform other duties as assigned.


KEY RELATIONSHIPS

INTERNAL

• In Silico Discovery and self-driving-laboratory leaders

• Therapeutic Area leaders and portfolio teams • CMC, Safety, PK/PD, Translational Sciences, and Development partners

• Protein engineering, protein sciences, functional biology, analytics, automation, and translational-quality teams

EXTERNAL

• Academic and research institutions

• Biotechnology, pharmaceutical, technology, and research partners

• Scientific advisors, collaborators, and professional networks


MEASURES OF SUCCESS

Success will be measured primarily by what the platforms enable downstream: better molecule choices, fewer avoidable development failures, stronger CMC readiness, and greater probability of clinical differentiation.

• Development-ready candidate quality. Candidates enter development with differentiated function, credible mechanism, robust developability, and a clear evidence package spanning safety, exposure, manufacturability, and translational rationale.

• Downstream risk reduction. Platform data and engineering decisions reduce late redesign, CMC surprises, formulation or stability failures, and avoidable delays in IND-enabling and clinical-development work.

• AI-native platform performance. Closed learning loops measurably improve predictive accuracy, engineering success rates, design-round efficiency, and the ability to optimize function and developability together across modalities.

• Platform durability and reuse. Modality platforms, data standards, models, assays, automation, and engineering playbooks are reused across programs, strengthened by downstream outcomes, and remain relevant from discovery through CMC and clinical translation.

• Clinical translation and differentiation. Platform choices produce molecules with stronger human-relevance evidence, clearer differentiation hypotheses, and measurable downstream performance that feeds back into the next generation of designs.


QUALIFICATIONS

REQUIRED

• Ph.D. in protein science, molecular or cell biology, biochemistry, bioengineering, computational biology, immunology, or a related field, or equivalent industry experience.

• Substantial industry experience in protein engineering, biologics discovery, functional biology, or related disciplines, with accountability for molecules that advanced through development-candidate selection and toward the clinic.

• Demonstrated ability to connect molecular design decisions to mechanism, potency, selectivity, functional activity, exposure, developability, manufacturability, and safety across complex biologic modalities.

• Hands-on experience integrating computational or machine-learning methods into experimental design and molecule selection, with clear examples where model output changed a scientific or program decision.

• Experience partnering with CMC, Safety, PK/PD, Translational Sciences, and Development to bring downstream requirements into early design and candidate-selection decisions.

• Experience establishing scalable discovery capabilities, data standards, decision frameworks, or closed learning loops that improved delivery across more than one program.

• Proven ability to lead multidisciplinary scientists and senior leaders, influence portfolio decisions, allocate resources, and deliver shared outcomes across organizational boundaries.

PREFERRED

Experience across antibodies and at least one additional modality such as multispecifics, ADCs, engineered proteins, or novel scaffolds.

• Direct involvement in an AI- or machine-learning-designed biologic that advanced into IND-enabling studies or the clinic.

• Experience building or materially reshaping a function rather than only operating an established organization.

• External visibility in protein engineering, biologics discovery, translational science, or machine learning for biology communities.


ROLE SCOPE AND INTERFACES

• Modality-platform ownership. The role owns the modality-platform, protein-engineering, functional, and translational-quality capabilities that enable portfolio teams to make better molecule and program decisions; it does not own the overall biologics portfolio.

• Computational platform partnership. Shared computational platforms are led through In Silico Discovery; this role defines biologics needs, applies the platforms to programs, and closes the learning loop through high-quality experimental data.

• Quality designed from the outset. Translational quality is designed into molecules from the outset, rather than assessed only after a candidate has been chosen.

• Outcome-oriented operating model. Success is measured by molecule quality, portfolio decisions, reusable learning, and downstream performance, not by activity volume alone.


OTHER REQUIREMENTS

• Ability to work at the Spring House, Pennsylvania or Cambridge, MA site in alignment with location requirements for the role.

• Ability to travel up to 25% domestic and international.


TRANSPARENCY
Subject to the terms of their respective plans, employees are eligible to participate in the Company’s consolidated retirement plan (pension) and savings plan (401(k)).

This position is eligible to participate in the Company’s long-term incentive program.

The anticipated base pay range for this position is $173,000 to $299,000.


Subject to the terms of their respective policies and date of hire, employees are eligible for the following time off benefits:

  • Vacation –120 hours per calendar year
  • Sick time - 40 hours per calendar year; for employees who reside in the State of Colorado –48 hours per calendar year; for employees who reside in the State of Washington –56 hours per calendar year
  • Holiday pay, including Floating Holidays –13 days per calendar year
  • Work, Personal and Family Time - up to 40 hours per calendar year
  • Parental Leave – 480 hours within one year of the birth/adoption/foster care of a child
  • Bereavement Leave – 240 hours for an immediate family member: 40 hours for an extended family member per calendar year
  • Caregiver Leave – 80 hours in a 52-week rolling period10 days
  • Volunteer Leave – 32 hours per calendar year
  • Military Spouse Time-Off – 80 hours per calendar year


For additional general information on Company benefits, please go to: - https://www.careers.jnj.com/employee-benefits

Johnson & Johnson is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state or local law. We actively seek qualified candidates who are protected veterans and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act.

Johnson and Johnson is committed to providing an interview process that is inclusive of our applicants’ needs. If you are an individual with a disability and would like to request an accommodation, please email the Employee Health Support Center (ra-employeehealthsup@its.jnj.com) or contact AskGS to be directed to your accommodation resource.

Required Skills:

Preferred Skills:

AI solution evaluation, Analytical Reasoning, Biochemistry, Chemistry, Manufacturing, and Control (CMC), Clinical Research and Regulations, Clinical Trial Designs, Developing Others, Drug Discovery Development, Inclusive Leadership, Leadership, Molecular Diagnostics, Operational Excellence, Pharmacovigilance, Process Improvements, Productivity Planning, Product Strategies, Representing, Scientific Research, Stakeholder Management

About Us

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.


Our Credo calls on us to respect the dignity of every individual and create an environment for all people to thrive. Throughout the recruitment process - from application through hiring - we are committed to providing reasonable accommodations/adjustments for qualified candidates with disabilities. If you need support at any stage of the recruitment process, please complete our candidate accommodation request form so we can assist you.

Apply for this job100% free